CF Acquisition VII Corp Unit (CFFSU) Peer Comparison
$11.18
$0.00 (0.00%)As on 17-Jun-2025 16:00EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 5,723 | 3,425 | 812 | 427 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 58 |
Net Profit ($ Mln) |
-2.71 | -1,435.01 | -118.30 | -134.20 | -50.70 |
Net Margin (%) |
-- | -325.91 | -4.10 | -- | -88.09 |
RoE (%) |
-5.76 | -- | -- | -40.17 | -54.90 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
-- | -- | 1.35 | -- | 2.89 |
Income Statement ($ Mln)
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 502.40 | 2,986.40 | -- | 77.44 |
|
Cost of Revenue
|
-- | 378.94 | 1,886.10 | -- | 103.71 |
|
Gross Profit
|
-- | 123.46 | 1,100.30 | -- | -26.27 |
|
Operating Expenses
|
1.46 | 114.50 | 960.60 | -- | 106.99 |
|
Operating Profit (EBIT)
|
-1.46 | 8.96 | 139.70 | -- | -133.25 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
4.44 | -245.80 | -72.70 | -- | -135.14 |
|
Provision for Tax
|
1.53 | 0.68 | 34.20 | -- | -114.28 |
|
Profit after Tax (Net Income)
|
2.91 | -246.49 | -93.50 | -- | -135.14 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
145.80 | -596.94 | -1,152.40 | -- | 68.34 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
155.01 | 820.67 | 2,487.60 | -- | 36.79 |
|
Current Liabilities
|
9.54 | 488.42 | 3,642.30 | -- | 48.67 |
|
Total Liabilities
|
155.34 | 712.16 | 5,103.00 | -- | 153.80 |
Assets ($ Mln)
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
155.18 | 615.14 | 3,730.90 | -- | 35.66 |
|
Current Assets
|
0.16 | 97.02 | 1,372.10 | -- | 118.14 |
|
Total Assets
|
155.34 | 712.16 | 5,103.00 | -- | 153.80 |
|
Total Debt*
|
8.46 | 865.55 | 3,721.30 | -- | 45.57 |
|
Net Current Assets
|
-9.38 | -391.41 | -2,270.20 | -- | 64.35 |
Cashflow ($ Mln)
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
2.91 | 65.11 | 488.90 | -- | -105.64 |
|
Cash Flow from Investing Activities
|
40.16 | -3.00 | -331.80 | -- | 38.89 |
|
Cash from Financing Activities
|
-40.16 | -44.65 | -74.90 | -- | 59.26 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
1.70 | 350.27 | -3.76 | -- | -98.08 |
|
ROE (%)
|
1.77 | 48.99 | 9.68 | -- | -130.48 |
|
ROA (%)
|
1.69 | -32.44 | -1.97 | -- | -71.72 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -49.06 | -3.13 | -- | -174.50 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -0.22 | -0.03 | -- | -0.02 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
4,339.62 | 88.52 | -31,066.67 | -- | -1,795.81 |
|
EPS Growth (%)
|
52.46 | 0.89 | -162.41 | -- | -8,683.78 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
71.65 | -0.21 | -5,142.26 | -- | 254.87 |
|
Price / Book Value
|
1.43 | -1.12 | -1.98 | -- | 14.63 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
16.16 | -- | 2.46 | -- | -19.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.06 | -1.45 | -3.23 | -- | 0.67 |
|
Short term debt to equity ratio
|
0.06 | -0.24 | -1.96 | -- | 0.34 |
|
Current Ratio
|
0.02 | 0.20 | 0.38 | -- | 2.43 |
|
Quick Ratio
|
-- | 0.21 | 0.39 | -- | 1.18 |
|
Interest Coverage
|
3.89 | -1.85 | 1.38 | -- | -12.90 |
Operating Efficiency Ratios
| CF Acquisition VII Corp Unit (CFFSU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 1.42 | 32.85 | -- | 28.68 |
|
Asset Turnover
|
0.00 | 0.66 | 0.63 | -- | 0.41 |
|
Receivable days
|
-- | 2.70 | 113.66 | -- | 86.78 |
|
Inventory Days
|
-- | -5.94 | -0.78 | -- | 232.47 |
|
Payable days
|
-- | 100.43 | 48.20 | -- | 49.41 |
|
Cash Conversion Cycle
|
-- | -103.67 | 64.67 | -- | 269.84 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
